Copyright Reports & Markets. All rights reserved.

Global Inflammatory Bowel Disease Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Inflammatory Bowel Disease Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Inflammatory Bowel Disease Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Aminosalicylates
    • 1.4.3 Antibiotics
    • 1.4.4 Corticosteroids
    • 1.4.5 Biologic therapies (biological drugs)
    • 1.4.6 Immunomodulators
  • 1.5 Market by Application
    • 1.5.1 Global Inflammatory Bowel Disease Market Share by Application: 2020 VS 2026
    • 1.5.2 Therapeutic
    • 1.5.3 Diagnostics
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Inflammatory Bowel Disease Market Perspective (2015-2026)
  • 2.2 Global Inflammatory Bowel Disease Growth Trends by Regions
    • 2.2.1 Inflammatory Bowel Disease Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Inflammatory Bowel Disease Historic Market Share by Regions (2015-2020)
    • 2.2.3 Inflammatory Bowel Disease Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Inflammatory Bowel Disease Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Inflammatory Bowel Disease Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Inflammatory Bowel Disease Players by Market Size
    • 3.1.1 Global Top Inflammatory Bowel Disease Players by Revenue (2015-2020)
    • 3.1.2 Global Inflammatory Bowel Disease Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Inflammatory Bowel Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Inflammatory Bowel Disease Market Concentration Ratio
    • 3.2.1 Global Inflammatory Bowel Disease Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Revenue in 2019
  • 3.3 Inflammatory Bowel Disease Key Players Head office and Area Served
  • 3.4 Key Players Inflammatory Bowel Disease Product Solution and Service
  • 3.5 Date of Enter into Inflammatory Bowel Disease Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Inflammatory Bowel Disease Historic Market Size by Type (2015-2020)
  • 4.2 Global Inflammatory Bowel Disease Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Inflammatory Bowel Disease Market Size by Application (2015-2020)
  • 5.2 Global Inflammatory Bowel Disease Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Inflammatory Bowel Disease Market Size (2015-2020)
  • 6.2 Inflammatory Bowel Disease Key Players in North America (2019-2020)
  • 6.3 North America Inflammatory Bowel Disease Market Size by Type (2015-2020)
  • 6.4 North America Inflammatory Bowel Disease Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Inflammatory Bowel Disease Market Size (2015-2020)
  • 7.2 Inflammatory Bowel Disease Key Players in Europe (2019-2020)
  • 7.3 Europe Inflammatory Bowel Disease Market Size by Type (2015-2020)
  • 7.4 Europe Inflammatory Bowel Disease Market Size by Application (2015-2020)

8 China

  • 8.1 China Inflammatory Bowel Disease Market Size (2015-2020)
  • 8.2 Inflammatory Bowel Disease Key Players in China (2019-2020)
  • 8.3 China Inflammatory Bowel Disease Market Size by Type (2015-2020)
  • 8.4 China Inflammatory Bowel Disease Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Inflammatory Bowel Disease Market Size (2015-2020)
  • 9.2 Inflammatory Bowel Disease Key Players in Japan (2019-2020)
  • 9.3 Japan Inflammatory Bowel Disease Market Size by Type (2015-2020)
  • 9.4 Japan Inflammatory Bowel Disease Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Inflammatory Bowel Disease Market Size (2015-2020)
  • 10.2 Inflammatory Bowel Disease Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Inflammatory Bowel Disease Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Inflammatory Bowel Disease Market Size by Application (2015-2020)

11 India

  • 11.1 India Inflammatory Bowel Disease Market Size (2015-2020)
  • 11.2 Inflammatory Bowel Disease Key Players in India (2019-2020)
  • 11.3 India Inflammatory Bowel Disease Market Size by Type (2015-2020)
  • 11.4 India Inflammatory Bowel Disease Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Inflammatory Bowel Disease Market Size (2015-2020)
  • 12.2 Inflammatory Bowel Disease Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Inflammatory Bowel Disease Market Size by Type (2015-2020)
  • 12.4 Central & South America Inflammatory Bowel Disease Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Bristol-Myers Squibb Company
    • 13.1.1 Bristol-Myers Squibb Company Company Details
    • 13.1.2 Bristol-Myers Squibb Company Business Overview
    • 13.1.3 Bristol-Myers Squibb Company Inflammatory Bowel Disease Introduction
    • 13.1.4 Bristol-Myers Squibb Company Revenue in Inflammatory Bowel Disease Business (2015-2020))
    • 13.1.5 Bristol-Myers Squibb Company Recent Development
  • 13.2 Baxter International
    • 13.2.1 Baxter International Company Details
    • 13.2.2 Baxter International Business Overview
    • 13.2.3 Baxter International Inflammatory Bowel Disease Introduction
    • 13.2.4 Baxter International Revenue in Inflammatory Bowel Disease Business (2015-2020)
    • 13.2.5 Baxter International Recent Development
  • 13.3 Johnson & Johnson
    • 13.3.1 Johnson & Johnson Company Details
    • 13.3.2 Johnson & Johnson Business Overview
    • 13.3.3 Johnson & Johnson Inflammatory Bowel Disease Introduction
    • 13.3.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Business (2015-2020)
    • 13.3.5 Johnson & Johnson Recent Development
  • 13.4 Sanofi-Aventis
    • 13.4.1 Sanofi-Aventis Company Details
    • 13.4.2 Sanofi-Aventis Business Overview
    • 13.4.3 Sanofi-Aventis Inflammatory Bowel Disease Introduction
    • 13.4.4 Sanofi-Aventis Revenue in Inflammatory Bowel Disease Business (2015-2020)
    • 13.4.5 Sanofi-Aventis Recent Development
  • 13.5 Abbott Laboratories
    • 13.5.1 Abbott Laboratories Company Details
    • 13.5.2 Abbott Laboratories Business Overview
    • 13.5.3 Abbott Laboratories Inflammatory Bowel Disease Introduction
    • 13.5.4 Abbott Laboratories Revenue in Inflammatory Bowel Disease Business (2015-2020)
    • 13.5.5 Abbott Laboratories Recent Development
  • 13.6 Pluristem Therapeutics
    • 13.6.1 Pluristem Therapeutics Company Details
    • 13.6.2 Pluristem Therapeutics Business Overview
    • 13.6.3 Pluristem Therapeutics Inflammatory Bowel Disease Introduction
    • 13.6.4 Pluristem Therapeutics Revenue in Inflammatory Bowel Disease Business (2015-2020)
    • 13.6.5 Pluristem Therapeutics Recent Development
  • 13.7 Pfizer
    • 13.7.1 Pfizer Company Details
    • 13.7.2 Pfizer Business Overview
    • 13.7.3 Pfizer Inflammatory Bowel Disease Introduction
    • 13.7.4 Pfizer Revenue in Inflammatory Bowel Disease Business (2015-2020)
    • 13.7.5 Pfizer Recent Development
  • 13.8 AstraZeneca
    • 13.8.1 AstraZeneca Company Details
    • 13.8.2 AstraZeneca Business Overview
    • 13.8.3 AstraZeneca Inflammatory Bowel Disease Introduction
    • 13.8.4 AstraZeneca Revenue in Inflammatory Bowel Disease Business (2015-2020)
    • 13.8.5 AstraZeneca Recent Development
  • 13.9 Cephalon
    • 13.9.1 Cephalon Company Details
    • 13.9.2 Cephalon Business Overview
    • 13.9.3 Cephalon Inflammatory Bowel Disease Introduction
    • 13.9.4 Cephalon Revenue in Inflammatory Bowel Disease Business (2015-2020)
    • 13.9.5 Cephalon Recent Development
  • 13.10 Amgen
    • 13.10.1 Amgen Company Details
    • 13.10.2 Amgen Business Overview
    • 13.10.3 Amgen Inflammatory Bowel Disease Introduction
    • 13.10.4 Amgen Revenue in Inflammatory Bowel Disease Business (2015-2020)
    • 13.10.5 Amgen Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Inflammatory Bowel Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inflammatory Bowel Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Bristol-Myers Squibb Company
    Baxter International
    Johnson & Johnson
    Sanofi-Aventis
    Abbott Laboratories
    Pluristem Therapeutics
    Pfizer
    AstraZeneca
    Cephalon
    Amgen

    Market segment by Type, the product can be split into
    Aminosalicylates
    Antibiotics
    Corticosteroids
    Biologic therapies (biological drugs)
    Immunomodulators
    Market segment by Application, split into
    Therapeutic
    Diagnostics

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now